NIH announces record number of grants to support early career investigators, launches new recruitment initiative for intramural research

Thursday, October 8, 2026

NIH announces record number of grants to support early career investigators, launches new recruitment initiative for intramural research

NIH highlights actions to strengthen American biomedical science at White House Science: A New Golden Age Summit.

The National Institutes of Health (NIH) today announced significant accomplishments that underscore the agency's progress in strengthening the U.S. biomedical research enterprise. The agency announced that 1,648 early-stage investigators are receiving NIH support through R01-equivalent extramural research grant awards in fiscal year 2026, the most ever recorded. The agency also launched Generation Discovery, a new initiative to recruit 100 early-career Principal Investigators into NIH's Intramural Research Program.

The NIH shared these and other recent accomplishments as part of the Science: A New Golden Age Summit, an event hosted by the White House Office of Science and Technology Policy (OSTP) to highlight the comprehensive rethinking of the U.S. science and technology enterprise in the Science: A New Golden Age report(link is external) and to showcase significant areas of progress.

"NIH is building the future of American biomedical science," said NIH Director Jay Bhattacharya. "That means demanding the highest standards of rigor, giving exceptional scientists the freedom to pursue bold ideas, attracting new talent, and putting powerful, innovative technologies to work. These actions will help turn scientific possibility into discoveries that improve and save lives."

The Trump Administration places a high priority on increasing opportunities for early-stage investigators to receive funding support to test new ideas. NIH has found that the average age of an extramural researcher serving for the first time as a principal investigator on a R01-equivalent grant has climbed(link is external) in recent decades, from 38 years old in FY1995 to 42 in FY2025. The 1,648 R01-equivalent grants awarded to support early-stage investigators in FY2026 represented a 25% increase over the ten-year average of 1,323.

With NIH's Intramural Research Program (IRP), Generation Discovery is a concerted effort to connect talented early-career researchers with the unparalleled resources and research opportunities found within the IRP.

Beyond these two announcements, NIH highlighted several other initiatives and accomplishments designed to reinvigorate American biomedical science.

Strengthening Scientific Rigor and Reproducibility

A cornerstone of NIH's efforts is strengthening replication and reproducibility - the ability to test scientific findings and determine whether they hold up when examined again. Because new discoveries build on earlier research, ensuring that findings are reliable is critical to advancing science and directing time and resources toward the most promising paths.

As part of this agency-wide initiative, NIH plans to establish its first metascience office. The office will serve as a central hub for studying and improving how biomedical science is conducted and coordinating NIH efforts to make rigorous, reproducible research a more integral part of the scientific enterprise.

Those efforts include the launch of a new NIH-wide program, known as Rigor, Replicability, & Reproducibility to Promote Excellence, Accuracy, & Translation in Science, or R3PEATS, that will support research, partnerships, infrastructure and training to improve the reliability of biomedical science. They also include NIH's Linked Discoveries, an experimental PubMed tool recently launched to help researchers see how individual findings fit within the broader body of biomedical evidence.

New Models for Tackling Complex Challenges

NIH is creating new ways to tackle complex scientific and technical challenges. In partnership with the National Science Foundation (NSF), NIH will advance X-Labs, a research model that brings together full-time, interdisciplinary teams with the resources, flexibility and operational independence to pursue ambitious technical goals that are difficult to address through traditional research approaches. NIH and NSF will seek input from the research community to identify potential X-Labs topics focused on priority biomedical research challenges.

Accelerating AI-Enabled Discovery

NIH is leading the Bio-Genesis Mission, part of the national Genesis Mission, to harness Super Intelligence (SI), data, and advanced computational approaches to accelerate biomedical discovery. Efforts include challenges focused on using SI and data to advance pediatric cancer research and repurpose generic drugs, work with the Department of Energy to build the cross-agency Genesis Mission Platform, and a new partnership with Biohub on virtual cell models for the Predicting Living Systems Challenge. NIH will also explore opportunities to develop scientists with expertise in SI and other scientific disciplines and connect trainees with Genesis Mission research opportunities at NIH and partner laboratories.

Developing Scientific Talent

NIH is expanding opportunities for scientists to pursue ambitious ideas and build independent research careers. In fiscal year 2026, NIH supported 1,648 early-stage investigators, the highest number in a single year in NIH history, as part of its commitment to helping early-career researchers establish independent scientific programs. NIH will also broaden its use of Investigator-Focused Awards (R35), which provide greater stability and flexibility to pursue promising scientific directions, and continue using prizes and challenges to spur new approaches to priority scientific and health problems.

NIH is extending that commitment to its own laboratories through Generation Discovery, a new initiative to recruit 100 outstanding investigators to the NIH Intramural Research Program over the next three years to pursue ambitious biomedical research.

Looking Ahead

Together, these efforts reflect NIH's commitment to strengthening the foundations of American biomedical research while creating new opportunities for discovery. By advancing rigorous and reproducible science, investing in the future of the research workforce, and developing new ways to tackle complex scientific challenges, NIH is working to accelerate discoveries that improve health and strengthen U.S. leadership in biomedical research.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH…Turning Discovery Into Health^®